Novo Nordisk (NVO) introduced a brand new $2.2 billion take care of San Francisco-based biotech Septerna (SEPN) for weight problems drugs — the newest in a sequence of strikes by
All posts tagged in Novo Nordisk
3Articles
Novo Nordisk (NVO) introduced a brand new $2.2 billion take care of San Francisco-based biotech Sapterna (SEPN) for weight problems tablets — the newest in a sequence of strikes by
Eli Lilly (LLY) has loved a profitable run the previous a number of quarters as the corporate’s blockbuster GLP-1 weight-loss drug Wegovy good points steam within the weight problems house.
Advertisement
